MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Botulinum toxin: Clinical applications: dystonia"

  • 2019 International Congress

    Clinical profile and treatment response patterns in patients of Truncal Dystonia: A retrospective case series from a tertiary care hospital in India

    S. Mehta, S. Ray, V. Lal (Chandigarh, India)

    Objective: To identify the clinical profile and treatment response patterns in patients with truncal dystonia. Background: Truncal Dystonia is characterized by involuntary contractions and postures…
  • 2019 International Congress

    Task Specific Dystonia and Its Response to Botulinum Neurotoxin Treatment

    R. Ortiz, T. Mertsalmi, F. Scheperjans, E. Pekkonen (Helsinki, Finland)

    Objective: To study the clinical features in task specific dystonia and its response to botulinum neurotoxin (BoNT) treatment. Background: Task specific dystonia is rare form…
  • 2019 International Congress

    Positive response to Botulinum Toxin injections in a patient with Painless Hand with Moving Fingers: A Case Report and Literature Review

    Z. Rosensweet, A. Persaud, E. Gaitour, N. Shneyder (Jacksonville, FL, USA)

    Objective: Objective: We present a rare case and literature review of Painless Hand with Moving Fingers (PHMF) that adequately responded to Onabotulinum toxin A (Botox)…
  • 2019 International Congress

    Classification of idiopathic cervical dystonia: an observational study

    P. Tater, N. Sarma, S. Pandey (New Delhi, India)

    Objective: The aim of our study was to classify patients with idiopathic cervical dystonia who had never been injected botulinum toxin. Background: Idiopathic cervical dystonia…
  • 2019 International Congress

    High Dose Botulinum Toxin Therapy: Safety, Benefit and Endurance of Efficacy

    S. Chiu, B. Patel, M. Burns, J. Legacy, A. Shukla, A. Ramirez-Zamora, W. Deeb, I. Malaty (Gainesville, FL, USA)

    Objective: To assess safety, therapeutic response and long-term benefit of higher dose Onabotulinum toxin A (OnaA). Background: Botulinum toxin therapy is a powerful tool for…
  • 2019 International Congress

    Effect of Botulinum Toxin Treatment on Cervical Dystonia

    S. Tomic, M. Tomasevic, D. Hardi, T. Gilman Kuric, Z. Popovic (Osijek, Croatia)

    Objective: To find out influence of botulinum toxin (BonT) treatment on improvement of motor symptoms and pain.To find out influence of botulinum toxin (BonT) treatment…
  • 2019 International Congress

    Botulinum toxin type A therapy in a movement disorders unit: a 23-year experience.

    M. Velez, C. Cosentino, L. Torres (Lima, Peru)

    Objective: To update the experience with botulinum toxin type A therapy at the Unidad de Movimientos Involuntarios (UMI) of Instituto Nacional de Ciencias Neurologicas (INCN)-Lima,…
  • 2019 International Congress

    Management of poor response to Botulinum toxin in cervical dystonia: a multicentre audit

    H. Tucker, F. Osei-Poku, D. Ashton, R. Lally, J. Alty, C. Kobylecki (Salford, United Kingdom)

    Objective: To audit the management of cervical dystonia patients with secondary poor responsiveness to BoNT in two regional U.K. neuroscience centres against the British Neurotoxin…
  • 2019 International Congress

    Effect of a Combined Treatment with Botulinum Toxin and Biofeedback Exercises in Pisa Syndrome

    A. Castagna, A. Crippa, D. Anastasi, M. Meloni, A. Montesano, A. Marzegan (Milano, Italy)

    Objective: To assess the efficacy of a combined botulinum neurotoxin (BoNT) treatment with biofeedback exercises in a single Parkinson Disease (PD) patient with Pisa Syndrome…
  • 2019 International Congress

    Tardive Cervical Dystonia: Treatment with Botulinum: Treatment with Botulinum Toxin Guided by Electromyography

    LFV. Vasconcellos, MS. Spitz, DN. Nassif, BRA. Andrade (Rio de Janeiro, Brazil)

    Objective: To describe the use of botulinum toxin in the treatment of tardive dystonia. Background: Tardive dystonia (TD) was recognized as a complication of dopamine…
  • « Previous Page
  • 1
  • …
  • 13
  • 14
  • 15
  • 16
  • 17
  • …
  • 23
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley